Transplant
Conference Coverage
Prevention of HMA failure a goal for high-risk MDS posttransplant
Conference Coverage
Are HMAS appropriate for posttransplant maintenance in acute leukemias?
Not yet, hematologist/oncologist tells colleagues at ALF meeting.
Conference Coverage
Novel treatments under study for chronic graft-versus-host disease in allo-HCT
Conference Coverage
Can AML patients be too old for cell transplantation?
Conference Coverage
Compound CAR T – a double whammy with promise for AML
For the first time, “a compound CAR with two independent CAR units induced remissions in AML.”
Conference Coverage
Tandem transplantation, long-term maintenance may extend MM remission
Conference Coverage
One-fifth of stem cell transplantation patients develop PTSD
“Clinically significant PTSD symptoms are common in the transplant population.”
Conference Coverage
Risk index stratifies pediatric leukemia patients undergoing HSCT
Conference Coverage
Erythema and sclerosis predict chronic GVHD clinical response, survival
"Our findings highlight the importance of thorough skin exams in chronic GVHD patients."
From the Journals
REACH2: Ruxolitinib outperformed control treatment for refractory acute GVHD
Ruxolitinib was significantly more effective against acute graft-versus-host disease but produced more thrombocytopenia than did control treatment...
From the Journals
CLAM trial regimen shown safe, effective for r/r AML
High response rates and effective bridge to transplant shown.